Dr. Guido Freckmann, MD, is Medical Director and General Manager of the “Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm” (IfDT), Ulm, Germany. The IfDT is an independent research organization specialized to diabetes technology. Dr. Freckmann is a general practitioner and diabetologist of the German Diabetes Association. As a study physician at the IfDT, he was principle investigator for different studies, about e.g. CGM systems, development of closed loop systems or insulin pumps and further diabetes technologies and cooperates with several industrial and non-industrial partners. His expertise in blood glucose monitoring systems (BGMS) contributed to the IfDT being accredited and internationally renowned as testing laboratory for BGMS following ISO 15197. Dr. Freckmann supports publication of all study results and is author of several scientific papers about BGMS or CGMS accuracy and further topics. In addition, he is member of the managing board of the diabetes technology working group (AGDT) and the commission for laboratory diagnostics (KLD) of the German Diabetes Association. He is member of the POCT section of the German Association of Clinical Chemistry. He’s also chairman of the working group on continuous glucose monitoring of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC).